National Highly Specialized Unit for Self-Harm Behaviours, Skåne
Lund, Skåne County, 22185, Sweden
Location status: Recruiting
Location contact
Magnus Nilsson, PhD
CONTACT
Magnus Nilsson, PhD
PRINCIPAL_INVESTIGATOR
Sofie Westling, MD/PhD
CONTACT
NCT Number: NCT06099561
The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm.
The main questions are:
1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions?
The secondary research questions are:
2. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm?
3. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions?
4. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions?
5. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata?
6. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?
Interested in participating?
Request Info18 year and older
All sexes
Observational
Lund, Skåne County, 22185, Sweden
Location status: Recruiting
Magnus Nilsson, PhD
CONTACT
Magnus Nilsson, PhD
PRINCIPAL_INVESTIGATOR
Sofie Westling, MD/PhD
CONTACT
Individuals with intractable, imminent and lethal self-harm often have multifaceted psychiatric symptoms, pervasive suffering, high mortality and a reduced level of daily functioning. Severe self-harm can lead to long periods of psychiatric inpatient care which can lead to reduced autonomy and aggravated self-harm. Effects of this care remain uncertain. The Swedish National Board of Welfare has provided National specialized medical care units for severe self-harm behaviour to three Swedish hospitals.
In one of this hospitals, Region Skåne, the intervention will be consultation-based. Individuals with intractable self-harm will be offered an assessment and review of all medical records which will result in a individualized intervention plan. Interventions include further assessments and supporting the existing treatment providers, families or caregivers. Recurring network-meetings will occur every three months as well as at he end of the intervention.
Data collection will include self-report measures as well as information from charts and national och regional registries.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Extensive assessments. Consultation and training for existing treatment providers and caregivers. Network-meetings for providers and caregivers.
Time frame: Monthly from baseline to endpointat 24 months and at follow-up at 36 months.
Level of daily functioning and disability in the domains of cognition, mobility, self-care, getting along with other people and life activities.
Time frame: Weekly from baseline to endpointat 24 months and at follow-up at 36 months.
Indirect and direct self-harming behaviour
Time frame: Monthly from baseline to endpointat 24 months and at follow-up at 36 months.
Quality of life scale
Time frame: Monthly from baseline to endpointat 24 months and at follow-up at 36 months.
Quantities and costs related to healthcare, municipal, social and rescue services.
Contact information is provided by the study sponsor or research team.
Magnus Nilsson, PhD
CONTACT
Sofie Westling, MD/PhD
CONTACT
Region Skane
Other
Svårbehandlat självskadebeteende-Vilka Insatser är Effektiva?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06315075
Behavior, Behavioral Symptoms
Bergen, Norway
View Trial DetailsNCT05304065
Behavior, Behavioral Symptoms
Los Angeles, California, United States
View Trial DetailsNCT06424509
Behavior, Behavioral Symptoms
Lund, Sweden
View Trial DetailsNCT06406972
Behavior, Behavioral Symptoms
Lund, Skåne County, Sweden
View Trial Details